Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Isabelle P. Sussman"'
Autor:
Sydney A. Caputo, Madeline Hawkins, Ellen B. Jaeger, William Fleming, Crystal Casado, Charlotte Manogue, Minqi Huang, Alex Lieberman, Malcolm Light, Isabelle P. Sussman, Patrick Miller, Pedro C. Barata, Brian E. Lewis, Jodi Lyn Layton, Elisa M. Ledet, Emmanuel S. Antonarakis, Oliver Sartor
Publikováno v:
The Prostate. 83:879-885
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::95c343a447b6c5e86af74a1d6b890072
https://doi.org/10.1002/pros.24529
https://doi.org/10.1002/pros.24529
Autor:
Charlotte Manogue, Grant Rauterkus, Malcolm Light, Isabelle P. Sussman, Alex Lieberman, Minqi Huang, Gaynelle Davis, Pedro C. Barata, Jodi Lyn Layton, Brian E. Lewis, Kendra Marie Harris, Hailey Manning, A. Oliver Sartor
Publikováno v:
Journal of Clinical Oncology. 40:TPS189-TPS189
TPS189 Background: A primary challenge facing oncologists is the accurate identification of the source of the rising PSA in the recurrent disease setting and the failure of proper staging at the time of initial therapy. Current imaging modalities per
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4b3a58bf000b6d990444dbd5454203d2
https://doi.org/10.1200/jco.2022.40.6_suppl.tps189
https://doi.org/10.1200/jco.2022.40.6_suppl.tps189
Autor:
Ellen B. Jaeger, Sydney Caputo, William Fleming, Charlotte Manogue, Alex Lieberman, Isabelle P. Sussman, Patrick Miller, Malcolm Light, Minqi Huang, Pedro C. Barata, Brian E. Lewis, Jodi Lyn Layton, Elisa M. Ledet, A. Oliver Sartor
Publikováno v:
Journal of Clinical Oncology. 40:24-24
24 Background: Somatic genetic analyses have indicated genetic distinctions in AA as compared to C patients. In the Mahal et al. study (1) evaluating a broad spectrum of pts with tissue based assays, FOXA1 mutations were more frequent in AA men and T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c317efd61819dc408cc4b4362eaed144
https://doi.org/10.1200/jco.2022.40.6_suppl.024
https://doi.org/10.1200/jco.2022.40.6_suppl.024
Autor:
Malcolm Light, Ellen B. Jaeger, Sydney Caputo, William Fleming, Charlotte Manogue, Minqi Huang, Isabelle P. Sussman, Alex Lieberman, Patrick Miller, Pedro C. Barata, Jodi Lyn Layton, Brian E. Lewis, Elisa M. Ledet, A. Oliver Sartor
Publikováno v:
Journal of Clinical Oncology. 40:177-177
177 Background: Germline alterations are found in approximately 12-17% of CRPC patients. Similarly, evaluating tumoral changes with circulating tumor DNA (ctDNA) has become an increasingly useful tool for understanding mechanisms underpinning disease
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e3c24f01fdabd68fffcc90133ec6bdc8
https://doi.org/10.1200/jco.2022.40.6_suppl.177
https://doi.org/10.1200/jco.2022.40.6_suppl.177
Autor:
Minqi Huang, Ellen B. Jaeger, Sydney Caputo, William Fleming, Malcolm Light, Charlotte Manogue, Isabelle P. Sussman, Alex Lieberman, Brian E. Lewis, Pedro C. Barata, Jodi Lyn Layton, Elisa M. Ledet, A. Oliver Sartor
Publikováno v:
Journal of Clinical Oncology. 40:275-275
275 Background: Circulating tumor-derived DNA (ctDNA) is an accessible method for characterizing somatic alterations. We report longitudinal ctDNA screenings of mCRPC patients (pts) who have had germline testing. Methods: Patients with both germline
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::039e585cf5ce081d08268e1560c39118
https://doi.org/10.1200/jco.2022.40.6_suppl.275
https://doi.org/10.1200/jco.2022.40.6_suppl.275